Hugo Peris

Hugo Peris is a pharma executive with extensive experience in medical devices, drug delivery, and drug development.1 He serves as a Board Advisor at StimuSIL, Inc., a medical device company developing photobiomodulation technologies for dermatology and aesthetics.13

Peris is also the founder and Chief Executive Officer of Spiral Therapeutics, a company based in San Francisco, CA.1 His career includes roles such as:

• Board member at Salvat Biotech (Spain)1
• Leader of business development at Luqa Pharmaceuticals (China) for nearly a decade, prior to its acquisition in 20211

In terms of education, Peris holds:

• A Bachelor's degree in International Business1
• A Master's degree in Health Economics and Pharmacoeconomics from Universitat Pompeu Fabra1

Recent activities on his LinkedIn profile (username: hugoperis) include:

• Sharing news about developments in the treatment of Meniere's Disease and a drug delivery platform called MICS™️ in July 20242
• Announcing his participation as a speaker at the 4th Inner Ear Disorders Therapeutics Summit in Boston, MA, scheduled for August 20-22, 20245
• Expressing excitement about being nominated for the Hearing Technology Innovator Awards™ in the therapeutics category in September 20234